retro-biosciences,-backed-by-sam-altman,-is-raising-$1-billion-to-extend-human-lifespan

Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan

In Brief

Posted:

Sam Altman speaks onstage during The New York Times Dealbook Summit 2024.
Image Credits:Eugene Gologursky/The New York Times / Getty Images
  • Charles Rollet

OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan.

Altman previously provided Retro Biosciences’ entire seed round of $180 million. Now, the startup is raising a $1 billion Series A that Altman is joining, The Financial Times reports.

Retro Biosciences, which says it plans to launch trials for drugs targeting diseases like Alzheimer’s, recently trained a model with OpenAI to turn regular cells into stem cells.

CEO Joe Betts-LaCroix told the FT he wants to move fast by discovering and developing a drug “in the 2020s.”

The startup joins other major billionaire-backed longevity efforts, including Altos Labs, which launched with $3 billion in 2022 backed by Jeff Bezos, and Unity Biotechnology, supported by both Bezos and Peter Thiel.

Newsletters

Subscribe for the industry’s biggest tech news

Related

Latest in Startups

yalova escort,yalova,eskort